R
Ronald T. Burkman
Researcher at Baystate Medical Center
Publications - 151
Citations - 9991
Ronald T. Burkman is an academic researcher from Baystate Medical Center. The author has contributed to research in topics: Population & Breast cancer. The author has an hindex of 43, co-authored 151 publications receiving 9454 citations. Previous affiliations of Ronald T. Burkman include University of Southern California & Henry Ford Health System.
Papers
More filters
Journal ArticleDOI
Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer
Brian L. Strom,Jesse A. Berlin,Anita L. Weber,Sandra A. Norman,Leslie Bernstein,Ronald T. Burkman,Janet R. Daling,Dennis Deapen,Suzanne G. Folger,Kathleen E. Malone,Polly A. Marchbanks,Michael S. Simon,Giske Ursin,Linda K. Weiss,Robert Spirtas +14 more
TL;DR: This study does not support an increased risk of breast cancer associated with the use of injectable or implantable progestin-only contraceptives in women aged 35 to 64.
Journal ArticleDOI
Bone mineral density in postmenarchal adolescent girls in the United States: associated biopsychosocial variables and bone turnover markers.
Zeev Harel,Melanie A. Gold,Barbara A. Cromer,Ann Bruner,Margaret Stager,Laura K. Bachrach,Kevin Wolter,Carol Reid,Paige Hertweck,Anita L. Nelson,Dorothy A. Nelson,Susan M. Coupey,Christine Cole Johnson,Ronald T. Burkman,Henry G. Bone +14 more
TL;DR: It is demonstrated that chronological age, gynecologic age, race/ethnicity, BMI, and previous history of pregnancy are markedly associated with BMD in postmenarchal adolescent girls.
Review article The evolution of combined oral contraception: improving the risk-to-benefit ratio
TL;DR: The combined oral contraceptive (COC) pill has become one of the most widely and frequently used methods of contraception worldwide as mentioned in this paper, however, early COC formulations were associated with significant adverse effects and unacceptable cardiovascular risk.
Journal ArticleDOI
Does standardization of care through clinical guidelines improve outcomes and reduce medical liability
TL;DR: This article will review some of the approaches to guideline development and provide evidence that their use may affect medical liability favorably and reduce variability in the process of care.
Journal ArticleDOI
The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders
TL;DR: The use of oral contraceptives reduces the risk of endometrial hyperplasia that may be associated with anovulatory states, and current low-dose preparations containing the newer progestins appear to be either neutral, or perhaps beneficial, with respect to their metabolic impact.